PKCthan staurosporine, K-252b attracted considerable interest as it is able to potentiate neurotrophin-3 actions in vitro9). In previous publications we described several minor metabolites of Streptomyceslongisporoflavus strain R-19 which were isolated as byproducts of a large scale staurosporine fermentation6' 1 0). In the present communication the structure elucidation, physicochemical data, and biological properties of further minor metabolites are described. Fermentation6) and isolation10) of the new compounds werereported earlier.
Results and Discussion Structure Elucidation K-252a (6) and K-252c (1) The two compounds gave virtually identical *H NMR and 13C NMR spectra as the reported ones8). MS investigation confirmed the identity of the structures.
TV-Methyl-staurosporine (4) High resolution EI-MS discloses the molecular formula of C29H28N4O3 and suggests an additional methyl group compared to staurosporine.
This substituent has to be located on the 4' nitrogen, as the *H NMRsignal of the TV-methyl group shows an integral corresponding to six hydrogens. Structure 4 is confirmed by irradiation on the N-(CH3)2 group in (CD3)2CO OCT. 1996 which gives rise to a NOEof20% on the 4' proton. The synthesis of 7V-methyl-staurosporine has already been described in a patent application12).
Af-Methyl-S'-amino-B'-deoxy-derivative of K-252a (5) The XHNMRof 5 is almost identical to that of the synthetic derivative 313) with the exception of an additional methyl group. This one must be located on the amino group as indicated by its chemical shift (1.9 ppm). As the coupling constants are also unchanged, the stereochemistry on center 3'n should be the same as in 3, which leads to structure 5. IR and 13C NMRspectra are fully consistent with the proposed structure. As expected the 13C NMRdata of3 and 5 are very similar with the exception of C-3' which is shifted by 6ppm to lower field in 5. Comparison of the CD spectra of5 and 3 shows that both compounds have the same absolute stereochemistry, which is identical to K-252a13) and probably the same at the bridging atoms 2'n and 5' or 6' as the recently determined absolute configuration of staurosporine1 1^B
iological Properties
Compound5 inhibits porcine PKC14) at a very similar concentration as K-252a ( Table 2 ). The selectivity pattern
for the two other kinases tested is also very similar, suggesting that the 3' amino group is not crucial for its biological activity. The PKC inhibition values of Nmethyl-staurosporine and staurosporine itself are indistinguishable.
The additional methyl group increases the selectivity towards c-AMPdependent protein kinases and phosphorylase kinase by a small factor of 3 to 6.
Biosynthetic Considerations
The main metabolite produced by the S-. longisporoflavus strain R-19 is staurosporine. Most minor metabolites are closely related either to staurosporine or to the oxime TAN-1030Awhich was also isolated6'10). Based on the rather surprising result that the same strain produces also K-252a (6) and another metabolite with a five-membered sugar moiety (5) as minor metabolites, a pathway for the last steps in the biosynthesis of K-252a is proposed (Fig, 1) .
The biosynthesis of staurosporine was investigated by Americanresearchers and two units of tryptophan were found to be incorporated into the aglycone moiety of this alkaloid15).
The aglycone K-252c (1) is the first characterized intermediate of the biosynthesis. As K-252d, another metabolite from the Nocardiopsis sp. K-2528), contains a L-rhamnose moiety, it seems to be likely that L-rhamnose is the biosynthetic precursor for the sugar moiety of most indolocarbazole type alkaloids. This hypothesis is supported by the fact that the absolute stereochemistry of L-rhamnose at C-4 and C-5 and of staurosporine at the centers 3' and 2' is identical11*. TAN-1030Ahas the same absolute stereochemistry as K-252a at the bridging atoms 2' and 5/13). TAN-1030A might be formed by oximation of the corresponding ketone derivative, another minor metabolite of strain R-1910), which could be easily formed by oxidation of a sugar hydroxy function.
In the course of synthetic studies of the oxime TAN-1030A (2) we found a new, synthetically useful, ring-contracting reaction which leads in one step to compound 3 under Beckmann conditions13).
It is therefore conceivable that TAN4030A (2) is a biosynthetic precursor which is converted by the microorganism to the proposed intermediate 3. This compounditself was not detected in the fermentation broth, but instead we found its TV-methyl derivative 5.
Compound5 might be formed from 3 by the same enzyme which introduces the TV-methyl group into staurosporine and which might to be unable to discriminate between substrates with five-and six-membered ring systems. The free amino group of intermediate 3 could be converted to the hydroxy group of K-252a (6). This metabolite was found to be co-produced in small amounts by our strain S. longisporoflavus R-19. It is noteworthy that the proposed biosynthetic reactions from 2 to K-252a proceed without loss and incorporation ofa carbon atom despite their structural differences.
In conclusion our worksuggests that most compounds of the staurosporine type are biosynthetically even more closely related than previously anticipated. 
